NG-19 Research: Axonis Therapeutics

Researchers from biomedical startup Axonis will launch an investigation on Northrop Grumman’s 19th Commercial Resupply Services mission to the space station seeking to improve treatments for patients suffering from neurological disorders. This video highlights how the space-based environment of the orbiting laboratory may facilitate the development of more effective treatments for patients on Earth.